Found: 14
Select item for more details and to access through your institution.
Association between Metabolic Disorders and Cholangiocarcinoma: Impact of a Postulated Risk Factor with Rising Incidence.
- Published in:
- Cancers, 2022, v. 14, n. 14, p. N.PAG, doi. 10.3390/cancers14143483
- By:
- Publication type:
- Article
Activated Lymphocytes and Increased Risk of Dermatologic Adverse Events during Sorafenib Therapy for Hepatocellular Carcinoma.
- Published in:
- Cancers, 2021, v. 13, n. 3, p. 426, doi. 10.3390/cancers13030426
- By:
- Publication type:
- Article
The complexity of cholangiocarcinoma goes beyond clinical practice: Challenges in trials design and interpretation.
- Published in:
- Liver International, 2022, v. 42, n. 2, p. 268, doi. 10.1111/liv.15149
- By:
- Publication type:
- Article
Pharmacokinetics and pharmacogenetics of sorafenib in patients with hepatocellular carcinoma: Implications for combination trials.
- Published in:
- Liver International, 2020, v. 40, n. 10, p. 2476, doi. 10.1111/liv.14587
- By:
- Publication type:
- Article
Increasing alternatives in systemic treatment for hepatocellular carcinoma: Will algorithms be understandable?
- Published in:
- Liver International, 2020, v. 40, n. 8, p. 1829, doi. 10.1111/liv.14584
- By:
- Publication type:
- Article
Adherence and quality are key for a beneficial HCC surveillance.
- Published in:
- Liver International, 2020, v. 40, n. 4, p. 751, doi. 10.1111/liv.14421
- By:
- Publication type:
- Article
The alpha and ßeta in phase II trials hepatocellular carcinoma ‐ A tale of more than radiological response?
- Published in:
- Liver International, 2019, v. 39, n. 8, p. 1391, doi. 10.1111/liv.14157
- By:
- Publication type:
- Article
Carbon‐ion radiotherapy for HCC—A potential tool to fulfil an unmet gap in the treatment algorithms?
- Published in:
- Liver International, 2018, v. 38, n. 12, p. 2132, doi. 10.1111/liv.13990
- By:
- Publication type:
- Article
Prognostic role of albumin-bilirubin (ALBI) score and Child-Pugh classification in patients with advanced hepatocellular carcinoma under systemic treatment.
- Published in:
- Ecancermedicalscience, 2024, v. 18, n. 1676-1753, p. 1, doi. 10.3332/ecancer.2024.1748
- By:
- Publication type:
- Article
A multidisciplinary approach to peritoneal metastasis from hepatocellular carcinoma: clinical features, management and outcomes.
- Published in:
- Clinical & Experimental Hepatology, 2022, v. 8, n. 1, p. 42, doi. 10.5114/ceh.2022.114297
- By:
- Publication type:
- Article
Circulating Tumor DNA Detection in the Management of Anti-EGFR Therapy for Advanced Colorectal Cancer.
- Published in:
- Frontiers in Oncology, 2019, p. N.PAG, doi. 10.3389/fonc.2019.00170
- By:
- Publication type:
- Article
Return to work after breast cancer diagnosis: An observational prospective study in Brazil.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Early variation of inflammatory indexes refines prognostic prediction in patients with hepatocellular carcinoma under systemic treatment.
- Published in:
- Molecular & Clinical Oncology, 2023, v. 18, n. 4, p. N.PAG, doi. 10.3892/mco.2023.2625
- By:
- Publication type:
- Article
Low Baseline Plasma L-Glutamine Concentration Identifies Hepatocellular Carcinoma Patients at High Risk of Developing Early Gastrointestinal Adverse Events during Sorafenib Treatment.
- Published in:
- Gastrointestinal Disorders, 2022, v. 4, n. 3, p. 141, doi. 10.3390/gidisord4030014
- By:
- Publication type:
- Article